Topic Hub
4 clinically reviewed articles, written and peer-reviewed by the HealthRX Medical Team.
Explore
Showing 4 of 4 clinical reviews.
Evolocumab (Repatha) is a biologic monoclonal antibody that cannot be replicated by compounding pharmacies. Learn why no compounded equivalent exists, how to reduce your out-of-pocket cost to as low as $5/month, and what biosimilar and alternative options are emerging in 2026.
Read clinical reviewHow Medicare Part D covers Repatha (evolocumab), what you will actually pay, manufacturer copay cards, patient assistance programs, and step-by-step strategies to lower your out-of-pocket cost in 2026.
Read clinical reviewA complete guide to the Repatha (evolocumab) manufacturer copay program from Amgen, including eligibility, savings amounts, insurance tips, and alternative ways to reduce your cost.
Read clinical reviewA complete guide to Repatha (evolocumab) patient assistance programs, copay cards, manufacturer support, and insurance strategies for low-income patients in 2026.
Read clinical review